Related Experiment Video
Updated: Jan 10, 2026
08:43
Chronic Ovine Model of Right Ventricular Failure and Functional Tricuspid Regurgitation
Published on: March 17, 2023
1.0K
Smaller defibrillation lead diameter is associated with less tricuspid regurgitation: a computational modeling study
David Oks1, Robert D Schaller2, Pamela K Mason3
1Cardiac Rhythm Management, Medtronic Inc., Minneapolis, MN, USA.
Expert Review of Medical Devices
|November 23, 2025
Summary
Thinner transvenous leads reduce tricuspid regurgitation (TR) by minimizing interference with heart valve function. This finding suggests thinner defibrillator leads may improve patient outcomes by reducing TR.
Area of Science:
- Cardiovascular device engineering
- Biomedical modeling
- Cardiac electrophysiology
Background:
- Tricuspid regurgitation (TR) negatively affects patient mortality and hospitalization rates.
- Transvenous pacemaker and defibrillator leads can exacerbate TR.
- Novel lead designs are needed to minimize tricuspid valve interference.
Purpose of the Study:
- To computationally evaluate the impact of transvenous lead characteristics on tricuspid regurgitation.
- To assess how lead diameter and material stiffness influence the regurgitant orifice area (ROA).
Main Methods:
- Developed a physics-based computational model to simulate lead-valve interactions.
- Evaluated ROA for leads with varying diameters (4.7 Fr, 6.8 Fr, 8.6 Fr) under different TR baseline conditions (none, mild, moderate).
Main Results:
- Lead diameter was a more significant factor than material stiffness in affecting ROA.
- Thicker leads (6.8 Fr, 8.6 Fr) exponentially increased ROA in mild and moderate TR.
- The 4.7 Fr lead showed minimal impact, while larger leads induced a transition from mild to moderate TR.
Conclusions:
- Simulations confirm that thinner leads reduce mechanical interference with tricuspid leaflet coaptation.
- These findings suggest thinner defibrillation leads could lead to improved clinical outcomes by mitigating TR.
